Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis

Neurorehabilitation and Neural Repair

Volumn 19, Issue 3, 2005, Pages 182-193

  Kübler, Andrea ^a   Winter, Susanne ^b   Ludolph, Albert C ^c   Hautzinger, Martin ^a   Birbaumer, Niels ^a,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Harlaching Hospital   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF TRENTO   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Depression; End of life decision; Life sustaining treatment; Quality of life

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS DEPRESSION INVENTORY; ARTICLE; BECK DEPRESSION INVENTORY; CAREGIVER; COPING BEHAVIOR; DEGENERATIVE DISEASE; DEPRESSION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; FEMALE; HIGH RISK PATIENT; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SCALES TO ASSESS QUALITY OF LIFE; SYMPTOMATOLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 24044432930     PISSN: 15459683     EISSN: None     Source Type: Journal    
DOI: 10.1177/1545968305276583     Document Type: Article

References (38)

1. McDonald ER, Hillel A, Wiedenfeld SA. Evaluation of the psychological status of ventilatory-supported patients with ALS/MND. Palliat Med 1996;10:35-41.
2. Trail M, Nelson ND, Van JN, Appel SH, Lai EC. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 2003; 209(1-2):79-85.
3. Bach JR. Ventilator use by muscular dystrophy association patients. Arch Phys Med Rehabil 1992;73:179-83.
4. Moss AH, Casey P, Stocking CB, Roos RP, Brooks BR, Siegler M. Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family and physician attitudes. Issues Neurol Pract 1993;43:438-43.
5. Christakis NA, Asch DA. Biases in how physicians choose to withdraw life support. Lancet 1993;342:642-6.
6. Bascom PB, Tolle SW. Responding to requests for physician-assisted suicide. J Am Med Assoc 2002;288:91-8.
7. Ganzini L, Johnston WS, McFarland BH, Tolle SW, Lee MA. Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide. N Engl J Med 1998;339(14):967-72.
8. Badger TA. Depression, psychological resources, and health-related quality of life. J Clin Geropsychol 2001;7:189-200.
9. McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis. The role of psychological factors. Arch Neurol 1994;51:17-23.
10. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100.
11. Turner RJ, Lloyd DA. The stress process and the social distribution of depression. J Health Soc Behav 1999;40(4):374-404.
12. Hecht M, Hillemacher T, Grasel E, et al. Subjective experience and coping in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2002;3(4):225-31.
13. Kübler A, Neumann N, Kaiser J, Kotchoubey B, Hinterberger T, Birbaumer NP. Brain-computer communication: self-regulation of slow cortical potentials for verbal communication. Arch Phys Med Rehabil 2001;82:1533-9.
14. Calzada Sierra DJ. [Bioethical considerations in the approach to patients with amyotrophic lateral sclerosis]. Rev Neurol 2001;32(10):952-7.
15. Norris FH, Calanchini PR, Fallal RJ, Panchari S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974;24:721-8.
16. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
17. Kübler A, Winter S, Kaiser J, Birbaumer N, Hautzinger M. Kin Fragebogen zur Messung von Depression bei degenerativen neurologischen Erkrankungen (amyotrophe Lateralsklerose)-A questionnaire to measure depression in degenerative neurological diseases. Z Klin Psychol Psychother 2005;31(1):19-26.
18. Rabkin JG, Wagner GJ, Bene MD. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 2000;62:271-9.
19. Averbeck M, Leiberich P, Grote-Kusch MT, et al. Skalen zur Erfassung der Lebensqualität (SKL)-Manual. Frankfurt: Swets & Zeitlinger B.V., Swets Test Services: 1997.
20. Chio A, Gauthier A, Montuschi A, et al. A cross sectional study on determinants of quality of life in MS. J Neurol Neurosurg Psychiatry 2004;75(11):1597-601.
21. Bromberg MB, Forshew DA. Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology 2002;58:320-2.
22. Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health-related quality of life. Qual Life Res 1993;2(6):369-95.
23. Ware JE Jr, Gandek B, Kosinski M, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. Int Qual Life Assess J Clin Epidemiol 1998;51(11):1167-70.
24. Jenkinson C, Hobart J, Chandola T, Fitzpatrick R, Peto V, Swash M. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. J Neurol 2002;249:178-83.
25. O'Boyle CA, Waldron D. Quality of life issues in palliative medicine. J Neurol 1997;244(Suppl 4):S18-25.
26. Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996;61:450-5.
27. Tedman BM, Young CA, Williams IR. Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. J Neurol Sci 1997;152:75-9.
28. Böcker FM, Seibold I, Neundörfer B. Behinderung im Alltag und subjektives Befinden bei Patienten mit fortgeschrittener myatrophischer Lateralsklerose (ALS). Fortschritte der Neurologie Psychiatrie 1990;58(6):224-36.
29. Hogg KE, Goldstein LH, Leigh PN. The psychological impact of motor neurone disease. Psychol Med 1994;1994:625-32.
30. Hunter MD, Robinson IC, Neilson S. The functional and psychological status of patients with amyotrophic lateral sclerosis: some implications for rehabilitation. Disabil Rehabil 1993;15(3):119-26.
31. Montgomery GK, Erickson LM. Neuropsychological perspectives in amyotrophic lateral sclerosis. Neurol Clin 1987;5(1):61-81.
32. Schulz P, Hellhammer D. Psychologische Aspekte chronischer Krankheiten. In: Reinecker H. ed. Lehrbuch der klinischen Psychologie-Modelle psychischer Störungen. 3rd ed. Göttingen Bern: Hogrefe; 1998:625-40.
33. Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology 1999;52:1434-40.
34. Borasio GD, Miller RG. Clinical characteristics and management of ALS. Semin Neurol 2001;21:155-67.
35. Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000;55(3):388-92.
36. Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology 2001;56:442-4.
37. Hickey AM, Bury G, O'Boyle CA, Bradley F, O'Kelly FD, Shannon W. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ 1996;313(7048):29-33.
38. Neudert C, Wasner M, Borasio GD. Patients assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001;191(1-2):103-9.